847039-05-8

Basic information

• Product Name: TERT-BUTYL 4-((BENZYLOXYCARBONYL)(METHYL)AMINO)PIPERIDINE-1-CARBOXYLATE
• Synonyms: TERT-BUTYL 4-((BENZYLOXYCARBONYL)(METHYL)AMINO)PIPERIDINE-1-CARBOXYLATE
• CAS NO: 847039-05-8
• Molecular Formula: C₁₉H₂₈N₂O₄
• Molecular Weight: 348.44
• Mol File: 847039-05-8.mol
• Article Data: 6

Chemical Properties

• Boiling Point: 455.2±44.0 °C(Predicted)
• Appearance: /
• Density: 1.14±0.1 g/cm3(Predicted)
• PKA: -1.48±0.20(Predicted)
• CAS DataBase Reference: TERT-BUTYL 4-((BENZYLOXYCARBONYL)(METHYL)AMINO)PIPERIDINE-1-CARBOXYLATE(CAS DataBase Reference)
• NIST Chemistry Reference: TERT-BUTYL 4-((BENZYLOXYCARBONYL)(METHYL)AMINO)PIPERIDINE-1-CARBOXYLATE(847039-05-8)
• EPA Substance Registry System: TERT-BUTYL 4-((BENZYLOXYCARBONYL)(METHYL)AMINO)PIPERIDINE-1-CARBOXYLATE(847039-05-8)

Safety Data

• Hazardous Substances Data: 847039-05-8(Hazardous Substances Data)

Upstream product

• 220394-97-8 4-(benzyloxycarbonylamino)-1-(tert-butoxycarbonyl)piperidine 
• 13139-17-8 N-(Benzyloxycarbonyloxy)succinimide 
• 147539-41-1 4-methylamino-piperidine-1-carboxylic acid tert-butyl ester 
• 501-53-1 benzyl chloroformate 
• 75315-63-8 N-(benzyloxycarbonyl)succinimide 
• 79099-07-3 N-tert-butyloxycarbonylpiperidin-4-one 
• 180695-80-1 tert-butyl 4-azidopiperidine-1-carboxylate 
• 180695-79-8 tert-butyl 4-bromo-1-piperidinecarboxylate 
• 87120-72-7 1-(tert-butoxycarbonyl)-4-aminopiperidine 
• 24424-99-5 di-tert-butyl dicarbonate 
• 90633-18-4 4-bromo-1H-piperidine 

Downstream Products

• 1365155-29-8 Benzyl 1-(2,6-dimethylpyrimidin-4-yl)piperidin-4-yl(methyl)carbamate 
• 1365156-43-9 Benzyl 1-(2-(dimethylamino)pyridin-4-yl)piperidin-4-yl(methyl)carbamate 
• 1365156-86-0 benzyl 1-(2-methoxy-6-methylpyrimidin-4-yl)piperidin-4-yl(methyl)carbamate 
• 1365156-60-0 Benzyl 1-(6-(dimethylamino)pyridin-3-yl)piperidin-4-yl(methyl)carbamate 
• 1365156-63-3 Benzyl 1-(2-methoxypyridin-4-yl)piperidin-4-yl(methyl)carbamate 

Relevant articles and documents

Rational Design, Synthesis, and Pharmacological Characterization of Novel Ghrelin Receptor Inverse Agonists as Potential Treatment against Obesity-Related Metabolic Diseases

A new chemotype of ghrelin inverse agonists was discovered through chimeric design based on molecular scaffolds known as growth-hormone secretagogue receptor (GHSR) modulators but with divergent pharmacodynamic and pharmacokinetic properties. The structur

SUBSTITUTED HETEROARYL COMPOUNDS AND METHODS OF USE

The present invention provides novel heterocyclic compounds, pharmaceutical acceptable salts and formulations thereof useful in preventing, treating or lessening the severity of a JAK-mediated disease. The invention also provides pharmaceutically acceptable compositions comprising such compounds and methods of using the compositions in the treatment of JAK-mediated disease.

Substituted triazole derivatives as oxytocin antagonists

The present invention relates to substituted triazoles of formula (I), uses thereof, processes for the preparation thereof and compositions containing said compounds. These inhibitors have utility in a variety of therapeutic areas including sexual dysfunction.